177 related articles for article (PubMed ID: 19583718)
21. [Bladder tumor targeting by Hexvix(®) fluorescence: 4 years results after prospective monocentric evaluation].
Ferré A; Cordonnier C; Demailly M; Hakami F; Sevestre H; Saint F
Prog Urol; 2013 Mar; 23(3):195-202. PubMed ID: 23446284
[TBL] [Abstract][Full Text] [Related]
22. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
Drăgoescu O; Tomescu P; Pănuş A; Enache M; Maria C; Stoica L; Pleşea IE
Rom J Morphol Embryol; 2011; 52(1):123-7. PubMed ID: 21424043
[TBL] [Abstract][Full Text] [Related]
24. [Fluorescent diagnostics of urinary bladder cancer].
Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
Urologiia; 2000; (4):3-6. PubMed ID: 11186690
[TBL] [Abstract][Full Text] [Related]
25. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
26. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
27. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Stenzl A; Penkoff H; Dajc-Sommerer E; Zumbraegel A; Hoeltl L; Scholz M; Riedl C; Bugelnig J; Hobisch A; Burger M; Mikuz G; Pichlmeier U
Cancer; 2011 Mar; 117(5):938-47. PubMed ID: 21351082
[TBL] [Abstract][Full Text] [Related]
28. ["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].
Forster TH; Wyler S; Ruszat R; Gasser TC; Bachmann A
Praxis (Bern 1994); 2007 Oct; 96(42):1631-7. PubMed ID: 17974123
[TBL] [Abstract][Full Text] [Related]
29. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
30. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
31. Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.
Rose JB; Armstrong S; Hermann GG; Kjellberg J; Malmström PU
BJU Int; 2016 Jun; 117(6B):E102-13. PubMed ID: 26305667
[TBL] [Abstract][Full Text] [Related]
32. Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro.
Steinberg G
J Urol; 2016 Jun; 195(6):1652-3. PubMed ID: 26995542
[No Abstract] [Full Text] [Related]
33. [Hexvix induced fluorescence blue light cystoscopy--a new perspective in superficial bladder tumors diagnosis].
Geavlete B; Mulţescu R; Georgescu D; Geavlete P
Chirurgia (Bucur); 2008; 103(5):559-64. PubMed ID: 19260632
[TBL] [Abstract][Full Text] [Related]
34. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
[TBL] [Abstract][Full Text] [Related]
35. Blue Light Cystoscopy: Indications and Outcomes.
Pohar KS
Curr Urol Rep; 2020 Apr; 21(5):19. PubMed ID: 32248340
[TBL] [Abstract][Full Text] [Related]
36. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Schmidbauer J; Marberger M
Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
[TBL] [Abstract][Full Text] [Related]
38. Novel endoscopic diagnosis for bladder cancer.
Lerner SP; Goh A
Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
[TBL] [Abstract][Full Text] [Related]
39. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
40. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
Witjes JA; Douglass J
Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
